Circulation

Heart Disease and Stroke Statistics - 2023 Update: A Report from the American Heart Association.  147:E93-E621. 2023

Stages of Valvular Heart Disease among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.  147:638-649. 2023

Long-Term Adverse Outcomes in Black Women with Ischemia and No Obstructive Coronary Artery Disease: A Study of the WISE (Women's Ischemia Syndrome Evaluation) Cohort.  147:617-619. 2023

Prospective Association of Daily Steps with Cardiovascular Disease: A Harmonized Meta-Analysis.  147:122-131. 2023

2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.  146:E334-E482. 2022

TBX20 Improves Contractility and Mitochondrial Function during Direct Human Cardiac Reprogramming.  146:1518-1536. 2022

Mechanical Circulatory Support Devices Among Patients With Familial Dilated Cardiomyopathy: Insights From the INTERMACS.  146:1486-1488. 2022

Tachycardia Associated With Pacing.  146:1475-1477. 2022

Long-Term Mortality Follow-Up of Radial Artery Versus Saphenous Vein in Coronary Artery Bypass Grafting: A Multicenter, Randomized Trial.  146:1323-1325. 2022

Impact of Sacubitril/Valsartan Compared with Ramipril on Cardiac Structure and Function after Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy.  146:1067-1081. 2022

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.  146:657-672. 2022

Escalating and De-escalating Temporary Mechanical Circulatory Support in Cardiogenic Shock: A Scientific Statement From the American Heart Association.  146:E50-E68. 2022

Association of Cardiovascular Health Through Young Adulthood with Genome-Wide DNA Methylation Patterns in Midlife: The CARDIA Study.  146:94-109. 2022

Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants.  146:110-124. 2022

Single Nucleus Transcriptomics: Apical Resection in Newborn Pigs Extends the Time Window of Cardiomyocyte Proliferation and Myocardial Regeneration.  145:1744-1747. 2022

Abstract 018: Whole Genome Sequence Analysis Of Apparent Treatment Resistant Hypertension Status In Participants From The Trans-omics For Precision Medicine Program.  145. 2022

Abstract 037: Multimorbidity Is Associated With Lower 24-hour Total Movement Activity Among US Adults.  145. 2022

Abstract MP28: Associations Of Adverse Childhood Family Environment With Adult Sedentary Behavior And Physical Activity: The Coronary Artery Risk Development In Young Adults (CARDIA) Study.  145. 2022

Abstract MP29: Higher Levels Of Leisure Physical Activity In Mid-life And Attenuated Physical Function Declines In Late-life: The Atherosclerosis Risk In Communities Study.  145. 2022

Abstract MP75: Cardiac Biomarkers And Frailty In The Atherosclerosis Risk In Communities (ARIC) Study.  145. 2022

Abstract P077: Midlife Physical Activity Is Associated With Gut Microbial Species And Metabolic Pathways: Coronary Artery Risk Development In Young Adults Study.  145. 2022

Heart Disease and Stroke Statistics-2022 Update: A Report from the American Heart Association.  145:E153-E639. 2022

Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination.  145:345-356. 2022

Genetic European Ancestry and Incident Diabetes in Black Individuals: Insights from the SPRINT Trial.  15:E003468. 2022

Health Behavior Change Programs in Primary Care and Community Practices for Cardiovascular Disease Prevention and Risk Factor Management among Midlife and Older Adults: A Scientific Statement from the American Heart Association.  144:E533-E549. 2021

Systems of Care for ST-Segment-Elevation Myocardial Infarction: A Policy Statement From the American Heart Association.  144:e310-e327. 2021

SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes.  144:256-266. 2021

Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction.  144:210-228. 2021

Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association.  144:E16-E35. 2021

Association of Blood Pressure Classification Using the 2017 American College of Cardiology/ American Heart Association Blood Pressure Guideline with Risk of Heart Failure and Atrial Fibrillation.  143:2244-2253. 2021

Abstract 071: Ten-year Change In Tv Viewing Is Associated With Concurrent Change In Pericardial Adipose Tissue In Middle-aged Adults: The Coronary Artery Risk Development In Young Adults (CARDIA) Study.  143. 2021

Abstract MP24: Sedentary Behavior (SB) In Mid-life And Structural Brain Magnetic Resonance Imaging (MRI) Markers Of Cerebrovascular Disease And Neurodegeneration In Late-life: The Atherosclerosis Risk In Communities Neurocognitive Study (ARIC-NCS).  143. 2021

Abstract P149: Sedentary Behavior In Mid-life And Risk Of Change In Global Cognitive Function And Incident Dementia: The Atherosclerosis Risk In Communities Neurocognitive Study (ARIC-NCS).  143. 2021

Abstract P154: Leisure-Time Physical Activity, Sedentary Behavior, And Carotid Atherosclerosis Morphology: The ARIC Carotid-MRI Study.  143. 2021

Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association.  143:E902-E916. 2021

Targeting 5-HT2B Receptor Signaling Prevents Border Zone Expansion and Improves Microstructural Remodeling after Myocardial Infarction.  143:1317-1330. 2021

Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial.  143:1109-1122. 2021

Gestational Diabetes History and Glucose Tolerance After Pregnancy Associated With Coronary Artery Calcium in Women During Midlife The CARDIA Study.  143:974-987. 2021

Heart Disease and Stroke Statistics - 2021 Update: A Report From the American Heart Association.  143:E254-E743. 2021

Ten-Year Differences in Women's Awareness Related to Coronary Heart Disease: Results of the 2019 American Heart Association National Survey: A Special Report From the American Heart Association.  143:E239-E248. 2021

Trends in Recurrent Coronary Heart Disease after Myocardial Infarction among US Women and Men between 2008 and 2017.  143:650-660. 2021

Number of Social Determinants of Health and Fatal and Nonfatal Incident Coronary Heart Disease in the REGARDS Study.  143:244-253. 2021

A Wide QRS Tachycardia in a 17-Year-Old.  142:2475-2478. 2020

The New 2019 AHA/ACC Guideline on the Primary Prevention of Cardiovascular Disease.  142:2402-2404. 2020

By Releasing the Brakes with Immunotherapy, Are We Accelerating Atherosclerosis?.  142:2312-2315. 2020

Call to Action: Structural Racism as a Fundamental Driver of Health Disparities: A Presidential Advisory from the American Heart Association.  142:E454-E468. 2020

Abstract 17244: Obesity and Serial NT-proBNP Levels in Heart Failure: Insights From the GUIDE-IT Trial.  142. 2020

Abstract 17284: Geographic Variation in Cardiovascular Health Among American Adults.  142. 2020

Response by Schwartz et al to Letter Regarding Article, “Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial”.  142:E335-E336. 2020

Forty-Year Shifting Distribution of Systolic Blood Pressure With Population Hypertension Treatment and Control.  142:1524-1531. 2020

Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.  142:S366-S468. 2020

Part 7: Systems of care 2020 american heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care.  142:S580-S604. 2020

Empagliflozin in Heart Failure: Diuretic and Cardiorenal Effects.  142:1028-1039. 2020

Racial Differences in Serial NT-proBNP Levels in Heart Failure Management: Insights From the GUIDE-IT Trial.  142:1018-1020. 2020

Apical Resection Prolongs the Cell Cycle Activity and Promotes Myocardial Regeneration After Left Ventricular Injury in Neonatal Pig.  142:913-916. 2020

A Chief Complaint of i Am Going to Die!.  141:1927-1929. 2020

Addressing Social Determinants of Health in the Care of Patients with Heart Failure: A Scientific Statement from the American Heart Association.  141:e841-e863. 2020

Family Caregiving for Individuals with Heart Failure: A Scientific Statement from the American Heart Association.  141:e864-e878. 2020

Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.  141:1608-1617. 2020

Local Peroxynitrite Impairs Endothelial Transient Receptor Potential Vanilloid 4 Channels and Elevates Blood Pressure in Obesity.  141:1318-1333. 2020

Knockout of the Murine Ortholog to the Human 9p21 Coronary Artery Disease Locus Leads to Smooth Muscle Cell Proliferation, Vascular Calcification, and Advanced Atherosclerosis..  141:1274-1276. 2020

Abstract 38: Prospective Study of Midlife Sedentary Behavior, Physical Activity, and Cognitive Function: The CARDIA Study.  141. 2020

Abstract P375: Prospective Associations of Accelerometer-measured Physical Activity and Sedentary Time With Cardiometabolic Multimorbidity in the CARDIA Study.  141. 2020

Abstract P497: Association Between Accelerometer-estimated Physical Activity Intensity and Heart Rate Variability: Mediation by Glycemic Measures and Triglycerides (from The Cardia Study).  141. 2020

Abstract P498: Association of Steps Per Day With Diabetes, Hypertension, and Obesity Over 10 Years: Results From the Coronary Artery Risk Development in Young Adults Study.  141. 2020

Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment.  141:21-33. 2020

Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared with Men with Heart Failure and Preserved Ejection Fraction: Insights from PARAGON-HF.  338-351. 2020

Heart disease and stroke statistics—2020 update a report from the American Heart Association.  141:E139-E596. 2020

Neutrophil-derived S100A8/A9 amplify granulopoiesis after myocardial infarction.  1080-1094. 2020

Recommendations for cardiovascular health and disease surveillance for 2030 and beyond: A policy statement from the american heart association.  E104-E119. 2020

Single-Cell Transcriptomics: New Insights in Heart Research.  1720-1723. 2020

Sudden Cardiac Arrest Survivorship: A Scientific Statement from the American Heart Association.  E654-E685. 2020

Telecommunicator Cardiopulmonary Resuscitation: A Policy Statement from the American Heart Association.  E686-E700. 2020

Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES.  140:2054-2062. 2019

The Long and Short of Too Much Drinking.  140:2119-2121. 2019

2019 American Heart Association Focused Update on Advanced Cardiovascular Life Support: Use of Advanced Airways, Vasopressors, and Extracorporeal Cardiopulmonary Resuscitation during Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.  140:E881-E894. 2019

2019 American Heart Association Focused Update on Systems of Care: Dispatcher-Assisted Cardiopulmonary Resuscitation and Cardiac Arrest Centers: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.  140:E895-E903. 2019

Cardiomyocyte Homeodomain-Interacting Protein Kinase 2 Maintains Basal Cardiac Function via Extracellular Signal-Regulated Kinase Signaling.  140:1820-1833. 2019

Response by Jia et al to Letter Regarding Article, "high-sensitivity troponin i and incident coronary events, stroke, heart failure hospitalization, and mortality in the ARIC study".  140:E772-E773. 2019

Response by Lundberg et al to Letter Regarding Article, "hemoglobin β93 Cysteine Is Not Required for Export of Nitric Oxide Bioactivity from the Red Blood Cell".  140:E760-E761. 2019

Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.  140:1578-1589. 2019

Hospital Volume Association With Abdominal Aortic Aneurysm Repair Mortality: Analysis of the International Consortium of Vascular Registries.  140:1285-1287. 2019

Unlocking the Secrets of Mitochondria in the Cardiovascular System: Path to a Cure in Heart Failure—A Report from the 2018 National Heart, Lung, and Blood Institute Workshop.  140:1205-1216. 2019

Alternating QRS Morphologies and PR Intervals in a Desperately Ill Woman.  140:793-795. 2019

Functionally Competent DNA Damage-Free Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Myocardial Repair.  140:520-522. 2019

Effect of Alirocumab on Mortality after Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.  140:103-112. 2019

Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology.  140:E69-E89. 2019

Response by Bansal et al to Letter Regarding Article, "dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy".  139:E1035-E1036. 2019

Hemoglobin β93 Cysteine Is Not Required for Export of Nitric Oxide Bioactivity from the Red Blood Cell.  139:2654-2663. 2019

High-Sensitivity Troponin i and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.  139:2642-2653. 2019

An Infant With Hemodynamic Collapse.  139:2588-2590. 2019

Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial.  139:2542-2553. 2019

Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality: An Individual-Level Pooled Analysis of 30 Cohort Studies.  139:2422-2436. 2019

Unusual Pacing after Electrical Cardioversion.  139:2374-2376. 2019

Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association.  139:E891-E908. 2019

Limitations of Morphological Criteria.  139:1643-1645. 2019

Abstract 036: Contemporary Estimates of Obesity Incidence of Among Children in the United States.  139. 2019

Abstract 039: Low Levels of Moderate to Vigorous Physical Activity is Associated With Fewer Years Lived Free of Cardiovascular Disease: The Cardiovascular Lifetime Risk Pooling Project.  139. 2019

Abstract 041: Perceived and Objective Characteristics of the Neighborhood Environment Are Associated With Accelerometer Measured Sedentary Time and Physical Activity, the CARDIA Study.  139. 2019

Abstract MP31: Diurnal Patterns of Physical Activity and Cardiovascular Risk Factors Over 10 Years: Results From the Coronary Artery Risk Development in Young Adults Study.  139. 2019

Abstract P314: Physical Activity and Sedentary Behavior Phenotypes in a Majority-Minority Community-Based Sample: Houston TRAIN Study.  139. 2019

Abstract P317: Bidirectional Associations Between Accelerometer-Measured Sedentary Time, Physical Activity, and Weight Over 10 Years in the CARDIA Study.  139. 2019

Abstract P318: The Association of Physical Activity With Serum Metabolomics: Findings From the Atherosclerosis Risk in Communities (ARIC) Study.  139. 2019

Abstract P360: Blunted Hemodynamic Response to Acute Mental Stress Among African Americans With Coronary Heart Disease.  139. 2019

Abstract P422: Accelerometer-Determined Sedentary Time and Physical Activity Across Employment Status Categories in CARDIA.  139. 2019

Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.  139:e56-e528. 2019

Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients with Hereditary Transthyretin-Mediated Amyloidosis: Analysis of the APOLLO Study.  139:431-443. 2019

Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.  139:206-221. 2019

Refining Prediction of Atrial Fibrillation-Related Stroke Using the P2-CHA2DS2-VASc Score: ARIC and MESA.  139:180-191. 2019

Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.  139:24-36. 2019

Letter by Russell and Janz Regarding Article, "Association Between Early Hyperoxia Exposure After Resuscitation From Cardiac Arrest and Neurological Disability: A Prospective Multicenter Protocol-Directed Cohort Study".  138:2858-2859. 2018

2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.  138:e740-e749. 2018

Coronary Artery Calcium on Noncontrast Thoracic Computerized Tomography Scans and All-Cause Mortality: Genetic Epidemiology of COPD (COPDGene) Study.  138:2437-2438. 2018

Abstract 17349: The Biomimetic Cardiac Tissue Model (BCTM) Reproduces the Pathological Remodeling Seen in Hypertrophic and Dilated Cardiomyopathy.  138. 2018

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.  138:e272-e391. 2018

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary.  138:e210-e271. 2018

Wide QRS Complex After Catheter Ablation..  137:1634-1637. 2018

Response by Soliman et al to Letters Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)".  137:1300-1301. 2018

Heart disease and stroke statistics - 2018 update: A report from the American Heart Association.  137:E67-E492. 2018

PCSK9 variants, low-density lipoprotein cholesterol, and neurocognitive impairment reasons for geographic and racial differences in stroke study (REGARDS).  137:1260-1269. 2018

Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.  137:e30-e66. 2018

Proefferocytic Therapy Promotes Transforming Growth Factor-β Signaling and Prevents Aneurysm Formation..  137:750-753. 2018

Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.  71:109-118. 2018

Early regenerative capacity in the porcine heart.  138:2798-2808. 2018

Large cardiac muscle patches engineered from human induced-pluripotent stem cell-derived cardiac cells improve recovery from myocardial infarction in swine.  137:1712-1730. 2018

Regenerative potential of neonatal porcine hearts.  138:2809-2816. 2018

Supraventricular tachycardia with something missing.  137:2076-2079. 2018

Widening racial differences in risks for coronary heart disease.  137:1195-1197. 2018

Integrated Noninvasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients With Stable Coronary Artery Disease.  136:2325-2336. 2017

Pathologic Stimulus Determines Lineage Commitment of Cardiac C-kit+ Cells.  136:2359-2372. 2017

Increased Inflammation in Pericardial Fluid Persists 48 Hours after Cardiac Surgery.  136:2284-2286. 2017

Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association.  136:e393-e423. 2017

Abstract 21106: The Matrikine Proline-Glycine-Proline is Locally Generated Following Acute Arterial Vascular Injury.  136. 2017

Interleukin-10 inhibits bone marrow fibroblast progenitor cell-mediated cardiac fibrosis in pressure-overloaded myocardium.  136:940-953. 2017

Methodological standards for meta-analyses and qualitative systematic reviews of cardiac prevention and treatment studies a scientific statement from the American Heart Association.  136:e172-e194. 2017

Physical activity and prognosis in the TOPCAT trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist).  136:982-992. 2017

An irregular wide complex tachycardia.  136:773-775. 2017

Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension.  136:440-450. 2017

Incident cardiovascular disease among adults with blood pressure <140/90 mm Hg.  136:798-812. 2017

Black-White Differences in Incident Fatal, Nonfatal, and Total Coronary Heart Disease.  136:152-166. 2017

Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk): Insights from the Department of Veterans Affairs.  135:2572-2574. 2017

Response by Golwala et al to Letter Regarding Article, "implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".  135:e1200-e1202. 2017

Thresholds for Ambulatory Blood Pressure among African Americans in the Jackson Heart Study.  135:2470-2480. 2017

Electrocardiogram challenge syncope in a woman with Nausea and Diarrhea.  135:2073-2076. 2017

Added sugars and cardiovascular disease risk in children: A scientific statement from the American Heart Association.  135:e1017-e1034. 2017

Sources of dietary sodium.  135:1784-1787. 2017

Sources of sodium in US adults from 3 geographic regions.  135:1775-1783. 2017

Potential deaths averted and serious adverse events incurred from adoption of the SPRINT (systolic blood pressure intervention trial) intensive blood pressure regimen in the United States: Projections from NHANES (National Health and Nutrition Examination Survey).  135:1617-1618. 2017

Abstract P231: Cumulative Body Mass Index and Incident Prediabetes Over 30 Years of Follow Up: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.  135. 2017

Heart Disease and Stroke Statistics'2017 Update: A Report from the American Heart Association.  135:e146-e603. 2017

Meal Timing and Frequency: Implications for Cardiovascular Disease Prevention: A Scientific Statement from the American Heart Association.  135:e96-e121. 2017

Contemporary Assessment of Left Ventricular Diastolic Function in Older Adults: The Atherosclerosis Risk in Communities Study.  135:426-439. 2017

Heart Failure Stages among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.  135:224-240. 2017

Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis.  135:201-203. 2017

Revised framingham stroke risk profile to reflect temporal trends.  135:1145-1159. 2017

Association between Duration of Resuscitation and Favorable Outcome after Out-of-Hospital Cardiac Arrest: Implications for Prolonging or Terminating Resuscitation.  134:2084-2094. 2016

Variations in Abdominal Aortic Aneurysm Care: A Report from the International Consortium of Vascular Registries.  134:1948-1958. 2016

Pleiotropic Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors?.  134:1695-1696. 2016

Restoration of Hydrogen Sulfide Production in Diabetic Mice Improves Reparative Function of Bone Marrow Cells..  134:1467-1483. 2016

Should Patients with Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target?: A Protagonist View from the SPRINT Trial (Systolic Blood Pressure Intervention Trial).  134:1308-1310. 2016

Sedentary behavior and cardiovascular morbidity and mortality: A science advisory from the American Heart Association.  134:e262-e279. 2016

Updated clinical practice guidelines on heart failure: An international alignment.  134:e280-e281. 2016

Response to Letter Regarding Article, "MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis"..  133:e714. 2016

Reproductive risk factors and coronary heart disease in the women's health initiative observational study.  133:2149-2158. 2016

Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification.  133:1668-1687. 2016

Response to Letter Regarding Article, "incidence, cause, and comparative frequency of sudden cardiac death in national collegiate athletic association athletes: A decade in review".  133:e447. 2016

Abstract P122: The Predictive Ability and Validity of a Composite Physical Activity Score in Relation to Adiposity Measures: Coronary Artery Risk Development in Young Adults (CARDIA).  133. 2016

Abstract P160: Cross-sectional and Longitudinal Associations of Objective Sedentary Time, Physical Activity, and Obesity: The CARDIA Study.  133. 2016

Response to Letter Regarding Article, "southern Dietary Pattern is Associated with Hazard of Acute Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study".  133:e416. 2016

SPS3 Evidence Supports Intensive Blood Pressure Control.  133:552-554. 2016

Executive summary: Heart disease and stroke statistics-2016 update: A Report from the American Heart Association.  133:447-454. 2016

Heart disease and stroke statistics-2016 update a report from the American Heart Association.  133:e38-e48. 2016

Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies.  133:256-264. 2016

MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis..  133:291-301. 2016

Association of fruit and vegetable consumption during early adulthood with the prevalence of coronary artery calcium after 20 years of follow-up.  132:1990-1998. 2015

Ideal cardiovascular health during adult life and cardiovascular structure and function among the elderly.  132:1979-1989. 2015

Abstract 19094: Use of ACE Inhibitors or Angiotensin Receptor Blockers is Associated With a Significantly Lower Risk of 30-day All-cause and Heart Failure Readmissions and All-cause Mortality in Older Medicare Beneficiaries Hospitalized for Heart Failure Developing Acute Kidney Injury.  132. 2015

Part 4: Systems of care and continuous quality improvement: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care.  132:S397-S413. 2015

Sex-specific association of sleep apnea severity with subclinical myocardial injury, ventricular hypertrophy, and heart failure risk in a community-dwelling cohort.  132:1329-1337. 2015

Southern dietary pattern is associated with hazard of acute coronary heart disease in the reasons for geographic and Racial Differences in Stroke (REGARDS) study.  132:804-814. 2015

Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone.  132:402-414. 2015

The National Physical Activity Plan: A Call to Action from the American Heart Association A Science Advisory from the American Heart Association.  131:1932-1940. 2015

Treatment of hypertension in patients with coronary artery disease: A scientific statement from the american heart association, american college of cardiology, and american society of hypertension.  131:e435-e470. 2015

Abstract MP04: 25 year Physical Activity Trajectories and Development of Subclinical Coronary Artery Disease as Measured by Coronary Artery Calcium: the CARDIA Study.  131. 2015

Abstract P282: Does Cardiorespiratory Fitness Modify the Association Between Sitting Time and Obesity?.  131. 2015

Abstract P283: Association of Cardiorespiratory Fitness and Adiposity with Inflammatory Biomarkers in Young Adults.  131. 2015

Abstract P284: Exploring Differences in Self-Reported Moderate and Vigorous Physical Activity Among Hispanic Subgroups, Non-Hispanic Black, and Non-Hispanic White: National Health Interview Survey (NHIS), 1997-2012.  131:AP284-AP284. 2015

Heart disease and stroke statistics-2015 update : A report from the American Heart Association.  131:e29-e39. 2015

Adverse childhood experiences and blood pressure trajectories from childhood to young adulthood the georgia stress and heart study.  131:1674-1681. 2015

Antibody-mediated rejection in cardiac transplantation: Emerging knowledge in diagnosis and management: A scientific statement from the American Heart Association: Endorsed by the international society for heart and lung transplantation.  131:1608-1639. 2015

Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: The evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial.  132:27-39. 2015

Executive summary: Heart disease and stroke statistics-2015 update : A report from the American Heart Association.  131:434-441. 2015

Incidence, cause, and comparative frequency of sudden cardiac death in national collegiate athletic association athletes a decade in review.  132:10-19. 2015

Knockout of Adamts7, a novel coronary artery disease locus in humans, reduces atherosclerosis in mice.  131:1202-1213. 2015

Left atrial mural endocarditis secondary to mitral valve jet lesion.  131:1529-1530. 2015

Myocardial bridging in a man with non-ST-elevation myocardial infarction.  131:e373-e374. 2015

O-linked β-N-acetylglucosamine transferase directs cell proliferation in idiopathic pulmonary arterial hypertension.  131:1260-1268. 2015

Response to letter regarding article, "the learning curve for transradial percutaneous coronary intervention among operators in the United States: A study from the national cardiovascular data registry".  131:e358. 2015

Transdiaphragmatic rupture of hepatic abscess producing purulent pericarditis and pericardial tamponade.  131:e1-e2. 2015

Vitamin D therapy in individuals with prehypertension or hypertension the DAYLIGHT trial.  131:254-262. 2015

Temporal trends in the population attributable risk for cardiovascular disease: The atherosclerosis risk in communities study.  130:820-828. 2014

Epigenome-wide association study of fasting blood lipids in the genetics of lipid-lowering drugs and diet network study.  130:565-572. 2014

Cardiac fibroblast glycogen synthase kinase-3β regulates ventricular remodeling and dysfunction in ischemic heart.  130:419-430. 2014

Left anterior descending coronary artery occlusion secondary to metastatic squamous cell carcinoma presenting as st-segment-elevation myocardial infarction.  129. 2014

Inhibition of glycosphingolipid synthesis ameliorates atherosclerosis and arterial stiffness in apolipoprotein E-/-Mice and rabbits fed a high-fat and -cholesterol diet.  129:2403-2413. 2014

The learning curve for transradial percutaneous coronary intervention among operators in the united states: A study from the national cardiovascular data registry.  129:2277-2286. 2014

Inositol 1,4,5-trisphosphate receptors and human left ventricular myocytes.  129. 2014

Racial and regional differences in venous thromboembolism in the United States in 3 cohorts.  129:1502-1509. 2014

Application of the American Heart Association/American College of Sports Medicine adult preparticipation screening checklist to a nationally representative sample of US adults aged ≥40 years from the National Health and Nutrition Examination Survey 2001 to 2004.  129:1113-1120. 2014

Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy.  129:1139-1151. 2014

Running forward new frontiers in endurance exercise biology.  129:798-810. 2014

Executive summary: Heart Disease and Stroke Statistics - 2014 Update: A report from the American Heart Association.  129:399-410. 2014

Heart Disease and Stroke Statistics - 2014 Update: A report from the American Heart Association.  129. 2014

Comment on the reports of over-estimation of ASCVD risk using the 2013 AHA/ACC risk equation.  129:266-267. 2014

Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery.  129:157-172. 2014

Association of low-grade albuminuria with adverse cardiac mechanics: Findings from the hypertension genetic epidemiology network (hypergen) study.  129:42-50. 2014

CD82 restrains pathological Angiogenesis by altering lipid raft clustering and CD44 trafficking in endothelial cells.  130:1493-1504. 2014

Response to letter regarding article, "growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery.  130:e118-e119. 2014

High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice.  128:2364-2371. 2013

Secondary prevention of atherosclerotic cardiovascular disease in older adults: A scientific statement from the American heart association.  128:2422-2446. 2013

Age-Associated defects in epha2 signaling impair the migration of human cardiac progenitor cells.  128:2211-2223. 2013

Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes.  128:1286-1297. 2013

Thymosin β4 increases the potency of transplanted mesenchymal stem cells for myocardial repair.  128. 2013

AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: An analysis from the LDL-C assessment with proprotein convertase subtilisin kexin type 9 monoclonal antibody inhibition combined with statin therapy (LAPLACE)-thrombolysis in myocardial infarction (TIMI) 57 Trial.  128:962-969. 2013

Pathological ventricular remodeling: Therapies: Part 2 of 2.  128:1021-1030. 2013

Exercise standards for testing and training: A scientific statement from the American heart association.  128:873-934. 2013

Pathological ventricular remodeling: Mechanisms: Part 1 of 2.  128:388-400. 2013

Preliminary experience with social media for community consultation and public disclosure in exception from informed consent trials.  128:267-270. 2013

Mechanisms of cell therapy for clinical investigations: An urgent need for large-animal models.  128:92-94. 2013

Submassive pulmonary embolism where's the tipping point?.  127:2458-2464. 2013

Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention an updated report from the national cardiovascular data registry (2007-2012).  127:2295-2306. 2013

An egg-shaped cyst of the right interventricular septum.  127:2351-2352. 2013

Berlin heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children.  127:1702-1711. 2013

Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases.  127:1317-1329. 2013

US Secular Trends in Coronary Heart Disease, Heart Attack/Myocardial Infarction, and Stroke Prevalence, by Race/Ethnicity, 2005-2010.  127. 2013

Right ventricular perforation and pulmonary embolism with polymethylmethacrylate cement after percutaneous kyphoplasty.  127:1251-1253. 2013

H2S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase.  127:1116-1127. 2013

Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: Results of the randomized IMPRES study.  127:1128-1138. 2013

Functional consequences of human induced pluripotent stem cell therapy: Myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling.  127:997-1008. 2013

Response to letter regarding article, magnetic resonance imaging with 3-dimensional analysis of left ventricular remodeling in isolated mitral regurgitation: Implications beyond dimensions.  127. 2013

Executive summary: Heart disease and stroke statistics-2013 update: A Report from the American Heart Association.  127:143-152. 2013

Heart disease and stroke statistics-2013 update: A Report from the American Heart Association.  127. 2013

Synthetic ECG-gated cardiac computed tomography for in vivo imaging of the temporary total artificial heart.  127. 2013

The heart disease and stroke statistics-2013 update and the need for a national cardiovascular surveillance system.  127:21-23. 2013

Stroke after carotid stenting and endarterectomy in the carotid revascularization endarterectomy versus stenting trial (CREST).  126:3054-3061. 2012

Comprehensive annular and subvalvular repair of chronic ischemic mitral regurgitation improves long-term results with the least ventricular remodeling.  126:2720-2727. 2012

Platypnea-orthodeoxia syndrome as a presentation of hereditary hemorrhagic telangiectasia.  126:2645-2647. 2012

Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs: 2012 update: A statement for health care professionals from the American association of cardiovascular and pulmonary rehabilitation and the American Heart Association.  126:2535-2543. 2012

Clinical and angiographic risk stratification and differential impact on treatment outcomes in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial.  126:2115-2124. 2012

Coronary artery fistula after cardiac transplantation.  126:2144-2145. 2012

Third universal definition of myocardial infarction.  126:2020-2035. 2012

Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy caused by lipotoxicity.  126:1705-1716. 2012

Population approaches to improve diet, physical activity, and smoking habits: A scientific statement from the American heart association.  126:1514-1563. 2012

Response to letter regarding article percutaneous coronary intervention in patients with severe aortic stenosis: Implications for transcatheter aortic valve replacement.  126. 2012

Ascending-ramp biphasic waveform has a lower defibrillation threshold and releases less troponin i than a truncated exponential biphasic waveform.  126:1328-1333. 2012

Neurodevelopmental outcomes in children with congenital heart disease: Evaluation and management a scientific statement from the american heart association.  126:1143-1172. 2012

Cardiac rehabilitation: Call to action for healthcare providers.  126:671-673. 2012

Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB.  126:418-429. 2012

About fACE: Perioperative use of angiotensin-converting enzyme inhibitors.  126:249-251. 2012

Energy balance and obesity.  126:126-132. 2012

Magnetic resonance imaging with 3-dimensional analysis of left ventricular remodeling in isolated mitral regurgitation: Implications beyond dimensions.  125:2334-2342. 2012

Endothelial cells overexpressing interleukin-8 receptors reduce inflammatory and neointimal responses to arterial injury.  125:1533-1541. 2012

Increasing referral and participation rates to outpatient cardiac rehabilitation: The valuable role of healthcare professionals in the inpatient and home health settings: A science advisory from the american heart association.  125:1321-1329. 2012

Percutaneous coronary intervention in patients with severe aortic stenosis: Implications for transcatheter aortic valve replacement.  125:1005-1013. 2012

Myocardial deformation imaging: Current status and future directions.  125. 2012

Executive summary: Heart disease and stroke statistics-2012 update: A report from the American heart association.  125:188-197. 2012

Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death.  125:65-75. 2012

Heart disease and stroke statistics-2012 update: A report from the American heart association.  125. 2012

Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS): what have we learned and what will we learn?.  126:1401-1406. 2012

Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: A presidential advisory from the american heart association.  124:2951-2960. 2011

A Randomized Controlled Trial of beta 1-Receptor Blockade for Chronic Degenerative Mitral Regurgitation.  124. 2011

Extracorporeal Membrane Oxygenation Supported Cardiopulmonary Resuscitation Is Not Associated with Increased Survival Compared to Conventional Cardiopulmonary Resuscitation for Pediatric In-Hospital Cardiac Arrest in the United States.  124. 2011

Is Small Change Significant? Association of Small Differences in Life's Simple 7 and Mortality: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort.  124. 2011

Primary outcomes for resuscitation science studies: A consensus statement from the american heart association.  124:2158-2177. 2011

Response to letter regarding article, "incidence of sudden cardiac death in national collegiate athletic association athletes".  124. 2011

Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).  124:1811-1818. 2011

Prevention of overweight/obesity as a strategy to optimize cardiovascular health.  124:840-850. 2011

ACCF/AHA 2011 expert consensus document on hypertension in the elderly: A report of the american college of cardiology foundation task force on clinical expert consensus documents.  123:2434-2506. 2011

Triglycerides and cardiovascular disease: A scientific statement from the American Heart Association.  123:2292-2333. 2011

Transmural heterogeneity and remodeling of ventricular excitation- contraction coupling in human heart failure.  123:1881-1890. 2011

Transmural heterogeneity and remodeling of ventricular excitation- contraction coupling in human heart failure.  123:1881-1890. 2011

Getting to the heart of myocardial stem cells and cell therapy.  123:1771-1779. 2011

Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: Primary results from the folic acid for vascular outcome reduction in transplantation trial.  123:1763-1770. 2011

Incidence of sudden cardiac death in national collegiate athletic association athletes.  123:1594-1600. 2011

Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: A Guideline from the American Heart Association.  123:1243-1262. 2011

2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.  123. 2011

Heart disease and stroke statistics-2011 update: A report from the American Heart Association.  123. 2011

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): A report of the American college of cardiology foundation/American heart association task force on practice guidelines.  123:104-123. 2011

A Prospective Examination of the Obesity Paradox in Heart Failure: Insights from a Population Study.  122. 2010

A Prospective Population Study of the Rate and Risk of Hospitalization among Medicare-Eligible Community-Dwelling Older Adults with Incident Heart Failure.  122. 2010

Adiposity, Inflammation, and Risk for Death in Black and White Men and Women in the US: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.  122. 2010

Colesevelam in Combination with Metformin Significantly Reduces Low-Density Lipoprotein Particle Concentration in Patients with Early Type 2 Diabetes.  122. 2010

Increased Protein O-GlcNAcylation Inhibits TNF-alpha-Induced NFkB Signaling in Rat Aortic Smooth Muscle Cells.  122. 2010

Inhibition of STIM1 Oligomerization by Protein O-Linked N-Acetylglucosamine: A Novel Metabolically Mediated Regulation of Cardiomyocyte Calcium Overload.  122. 2010

Is the Obesity Epidemic Reversing Favorable Trends in Blood Pressure: Evidence from Cohorts Born between 1890 and 1990 in the United States.  122. 2010

Life's Simple 7 in 2003-2007 and Mortality in Blacks and Whites: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort.  122. 2010

Native Endothelium Mimicking Self-Assembled Nanomatrix for Drug-Eluting Stents.  122. 2010

Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the bypass angioplasty revascularization investigation 2 diabetes trial.  122:1690-1699. 2010

Part 9: Acute coronary syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations..  122:S422-S465. 2010

Chymase inhibition prevents fibronectin and myofibrillar loss and improves cardiomyocyte function and LV torsion angle in dogs with isolated mitral regurgitation.  122:1488-1495. 2010

Composite cell sheets: A further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells.  122. 2010

Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: Multicenter automatic defibrillator implantation trial: Cardiac resynchronization therapy.  122:985-992. 2010

Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart.  121:1912-1925. 2010

Executive summary: Heart disease and stroke statistics-2010 update: A report from the american heart association.  121. 2010

Heart disease and stroke statistics - 2010 update: A report from the American heart association.  121:948-954. 2010

Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure.  121:252-258. 2010

Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the bypass angioplasty revascularization investigation 2 diabetes trial.  120:2550-2558. 2009

Stem cells for myocardial repair with use of a transarterial catheter.  120. 2009

Native Endothelium Mimicking Self-Assembled Nanomatrix for Drug Eluting Stents.  120:S951-S951. 2009

Simultaneous Transmural Mapping of Voltage and Calcium in the Human Heart.  120:S667-S667. 2009

Simultaneous Transmural Measurements of V-m and Ca-j(2+) During Rapid Pacing and Long-Duration Ventricular Fibrillation in Canine Hearts.  120:S689-S689. 2009

ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: A report of the american college of cardiology foundation/american heart association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): Developed in collaboration with the american academy of family physicians.  120:1296-1336. 2009

Mortality, health outcomes, and body mass index in the overweight range: A science advisory from the american heart association.  119:3263-3271. 2009

Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity.  119:2818-2828. 2009

Stem cell therapy for heart failure: Are arrhythmias a real safety concern?.  119:2735-2740. 2009

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.  119:2545-2552. 2009

Criteria for evaluation of novel markers of cardiovascular risk: A scientific statement from the American heart association.  119:2408-2416. 2009

MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20.  119:2357-2366. 2009

Molecular cardiology microarray identifies extensive downregulation of noncollagen extracellular matrix and profibrotic growth factor genes in chronic isolated mitral regurgitation in the dog.  119:2086-2095. 2009

Distribution and Determinants of Doppler-Derived Diastolic Flow Indices in African Americans: The Jackson Heart Study.  119:E340-E340. 2009

Divergent tumor necrosis factor receptor-related remodeling responses in heart failure:Role of nuclear factor-κB and inflammatory activation.  119:1386-1397. 2009

Racial and Geographic Differences in Self-Reported Moderate or More Physical Activity: The REasons for Geographic And Racial Differences in Stroke (REGARDS).  119:E344-E344. 2009

Ionizing radiation in cardiac imaging: a science advisory from the American Heart Association Committee on Cardiac Imaging of the Council on Clinical Cardiology and Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention..  119:1056-1065. 2009

Heart disease and stroke statistics - 2009 update. A report from the American heart association statistics committee and stroke statistics subcommittee.  119:480-486. 2009

Heart disease and stroke statistics - 2009 update. A report from the American heart association statistics committee and stroke statistics subcommittee.  119:480-486. 2009

Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease. The coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis.  119:382-389. 2009

Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition.  118:1970-1978. 2008

Natural Endothelium Mimicking Self-Assembled Nanomatrix for Drug Eluting Stent Applications.  118:S962-S962. 2008

Transition from chronic compensated to acute d compensated heart failure: Pathophysiological insights obtained from continuous monitoring of intracardiac pressures.  118:1433-1441. 2008

Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: Results of the multicenter trial of the orqis medical cancion system for the enhanced treatment of heart failure unresponsive to medical therapy (MOMENTUM).  118:1241-1249. 2008

Population-based prevention of obesity: The need for comprehensive promotion of healthful eating, physical activity, and energy balance: A scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for prevention (formerly the expert panel on population and prevention science).  118:428-464. 2008

Marginally increased waist circumference predicts hypertension prevalence among normal and overweight adults: The REGARDS study.  117. 2008

Angina pectoris: Reversal of the gender gap.  117:1505-1507. 2008

Heart disease and stroke statistics-2008 Update: A report from the American heart association statistics committee and stroke statistics subcommittee.  117. 2008

Heme oxygenase-1 and carbon monoxide in vascular pathobiology: Focus on angiogenesis.  117:231-241. 2008

Proarrhythmic aspects of atrial fibrillation surgery: Mechanisms of postoperative macroreentrant tachycardias.  117:155-162. 2008

Skeletal myoblasts preserve remote matrix architecture and global function when implanted early or late after coronary ligation into infarcted or remote myocardium..  118. 2008

The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation.  117:1189-1200. 2008

CD36 expression contributes to age-induced cardiomyopathy in mice.  116:2139-2147. 2007

Activation patterns of Purkinje fibers during long-duration ventricular fibrillation in an isolated canine heart model.  116:1113-1119. 2007

Resistance exercise in individuals with and without cardiovascular disease: 2007 update: A scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism.  116:572-584. 2007

Core components of cardiac rehabilitation/secondary prevention programs: 2007 update - A sci. statement from the Am. Heart Assoc. exercise, cardiac rehabilitation, and prevention comm., the council on clinical cardiology; the councils on cardiovascular nursing, epidemiology and prevention, and nutrition, physical activity, and metabolism; and the Am. Assoc. of Cardiovasc. and Pulmonary Rehabil..  115:2675-2682. 2007

Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: Effects on macrophage recruitment, nuclear factor-κB nuclear translocation, and foam cell death.  115:2442-2450. 2007

Treatment of hypertension in the prevention and management of ischemic heart disease: A scientific statement from the American Heart Association council for high blood pressure research and the councils on clinical cardiology and epidemiology and prevention.  115:2761-2788. 2007

Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling.  115:1866-1875. 2007

Evidence-based guidelines for cardiovascular disease prevention in women: 2007 Update.  115:1481-1501. 2007

Medication adherence does not explain disparities in blood pressure control: The reasons for geographic and racial differences in stroke (REGARDS) study.  115:E288-E288. 2007

Perceived stress and depression: The impact of race and residence in the "Black Belt" region of the Southeastern United States.  115:E275-E276. 2007

The national prevalence of healthy lifestyles is low and varies by race and geographic region.  115:E280-E280. 2007

Trust in the patient-physician relationship is related to care-seeking behavior following stroke symptoms: The REasons for geographic and racial differences in stroke (REGARDS) study.  115:E259-E260. 2007

Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: The coronary artery risk development in young adults study.  115:1004-1011. 2007

Effect of high-dose atorvastatin on hospitalizations for heart failure: Subgroup analysis of the Treating to New Targets (TNT) study.  115:576-583. 2007

Heart disease and stroke statistics - 2007 Update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.  115. 2007

Essential features of a surveillance system to support the prevention and management of heart disease and stroke: A scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Stroke, and Cardiovascular Nursing and the Interdisciplinary Working Groups on Quality of Care and Outcomes Research and Atherosclerotic Peripheral Vascular Disease.  115:127-155. 2007

Trends in acute myocardial infarction in 4 US States between 1992 and 2001: Clinical characteristics, quality of care, and outcomes.  114:2806-2814. 2006

Continuity of epicardial activation during ventricular fibrillation in the isolated swine heart.  114:330-330. 2006

Protein O-glycosylation improves survival and effects cytokine release following trauma-hemorrhage in rats.  114:426-426. 2006

Relationship between aspirin, statins, the combination and C-reactive protein.  114:828-829. 2006

Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury.  114:1721-1728. 2006

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for practice guidelines (Writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation).  114:700-752. 2006

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for practice guidelines (Writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation).  114. 2006

Human ventricular fibrillation: Wandering wavelets, mother rotors, or both?.  114:530-532. 2006

The economic burden of angina in women with suspected ischemic heart disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.  114:894-904. 2006

Chordal cutting does not adversely affect left ventricle contractile function.  114. 2006

Skeletal myoblast transplantation in ischemic heart failure: Long-term follow-up of the first phase I cohort of patients.  114. 2006

Reciprocal relationships between insulin resistance and endothelial dysfunction: Molecular and pathophysiological mechanisms.  113:1888-1904. 2006

Pulsology rediscovered: Commentary on the Conduit Artery Function Evaluation (CAFE) study.  113:1162-1163. 2006

You can't judge a book by its cover.  113:1275-1277. 2006

Racial differences in intensity of hypertension treatment: The reasons for geographic and racial disparities in stroke study.  113:E309-E309. 2006

Relationship for stroke and heart disease between the average Framingham Risk Scores with cause-specific mortality at the state level.  113:E312-E312. 2006

Heart disease and stroke statistics - 2006 Update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.  113. 2006

Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation.  113:544-554. 2006

Standards for statistical models used for public reporting of health outcomes: An American Heart Association scientific statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group.  113:456-462. 2006

Cell-based cardiac repair reflections at the 10-year point.  112:3174-3183. 2005

ICAM-1 governs angiogenesis via regulation of eNOS activity: Role of glutathione and PTEN.  112:U156-U156. 2005

Modified lipoprotein-immune complexes and progression of internal carotid intima-media thickness in type 1 diabetes.  112:U848-U849. 2005

Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice.  112:2668-2676. 2005

Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity.  112:2686-2695. 2005

Mutations in transforming growth factor-β receptor type II cause familial thoracic aortic aneurysms and dissections.  112:513-520. 2005

Apolipoprotein E mimetic peptide dramatically lowers plasma cholesterol and restores endothelial function in Watanabe heritable hyperlipidemic rabbits.  111:3112-3118. 2005

Impact of high glucose/high insulin and dichloroacetate treatment on carbohydrate oxidation and functional recovery after low-flow ischemia and reperfusion in the isolated perfused rat heart.  111:2066-2072. 2005

Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: The LIFE (Losartan Intervention for Endpoint reduction in hypertension) study.  111:1924-1931. 2005

Differences in predicted 10-year risk of stroke by region and race.  111:E212-E213. 2005

High prevalence of stroke symptoms in a general population without a history of stroke or TIA: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.  111:E213-E213. 2005

National distribution of C-reactive protein in African-Americans and whites: The reasons for geographic and racial differences in stroke (REGARDS) study.  111:E226-E226. 2005

Gender and peri-procedural stroke and death following carotid artery stenting: An update from the CREST lead-in phase.  111:E49-E49. 2005

Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model.  111:150-156. 2005

Prenatal environmental tobacco smoke exposure promotes adult atherogenesis and mitochondrial damage in apolipoprotein E^-/- mice fed a chow diet.  110:3715-3720. 2004

D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes.  110:3252-3258. 2004

Restitution properties during ventricular fibrillation in the in situ swine heart.  110:3161-3167. 2004

Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group II: age-dependent risk factors for obesity and comorbidities..  110. 2004

Protection from ischemic and hypovolemic injury by hyperglycemia transduced by hexosamine biosynthesis and O-linked N-acetylglucosamine on cytoplasmic proteins.  110:1099-1099. 2004

Role of microscopic tissue structure in shock-induced activation assessed by optical mapping in myocyte cultures.  110:98-98. 2004

Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.  110:1960-1966. 2004

Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy?.  110:1626-1631. 2004

Estrogen modulates inflammatory mediator expression and neutrophil chemotaxis in injured arteries.  110:1664-1669. 2004

Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.  110:292-300. 2004

Electrophysiological findings in adolescents with atrial fibrillation who have structurally normal hearts.  110:117-123. 2004

Blood pressure reactivity to psychological stress predicts hypertension in the CARDIA study.  110:74-78. 2004

Hypertensive therapy: Part I.  109:2953-2958. 2004

Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).  109:2993-2999. 2004

Air pollution and cardiovascular disease: A statement for healthcare professionals from the expert panel on population and prevention science of the American Heart Association.  109:2655-2671. 2004

Neurological events during long-term mechanical circulatory support for heart failure: The Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience.  109:2423-2427. 2004

Short-acting β-adrenergic antagonist esmolol given at reperfusion improves survival after prolonged ventricular fibrillation.  109:2469-2474. 2004

Intramural virtual electrodes in ventricular wall: Effects on epicardial polarizations.  109:2349-2356. 2004

Resumption of Electrical Conduction in Previously Isolated Pulmonary Veins: Rationale for a Different Strategy?.  109:1226-1229. 2004

Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in Women: A Report from the Women's Ischemia Syndrome Evaluation (WISE) Study.  109:706-713. 2004

C-Reactive Protein Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice.  109:647-655. 2004

Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women.  109:672-693. 2004

Estradiol and Progestins Differentially Modulate Leukocyte Infiltration after Vascular Injury.  109:234-241. 2004

Hypertensive therapy: Part II..  109:3081-3088. 2004

Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice..  109:3215-3220. 2004

Influenza and Cardiovascular Disease: A New Opportunity for Prevention and the Need for Further Studies.  108:2730-2736. 2003

Does the stroke risk of stenting increase at older ages? Thirty-day stroke - Death rates in the CREST lead-in phase.  108:461-461. 2003

Increased oxidation of free fatty acids does not lead to increased susceptibility to ischemia in hearts from type-2 diabetic rats.  108:17-17. 2003

Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels.  108:2000-2006. 2003

From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part II.  108:1772-1778. 2003

From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I.  108:1664-1672. 2003

Efficacy of chordal cutting to relieve chronic persistent ischemic mitral regurgitation.  108. 2003

Efficacy of chordal cutting to relieve chronic persistent ischemic mitral regurgitation..  108 Suppl 1:II111-II115. 2003

Transplantation of autologous fresh bone marrow into infarcted myocardium: A word of caution.  108. 2003

Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution..  108 Suppl 1:II247-II252. 2003

Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice.  108:754-759. 2003

Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor.  108:598-604. 2003

Evidence for longitudinal and transverse fiber conduction in human pulmonary veins: Relevance for catheter ablation.  108:590-597. 2003

Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice.  108:512-515. 2003

β1-adrenergic receptor blockade attenuates angiotensin II-mediated catecholamine release into the cardiac interstitium in mitral regurgitation.  108:225-230. 2003

Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: Enhancement by tissue necrosis factor-α, interleukin-1β, and interferon-γ.  107:1545-1549. 2003

A test of an innovative approach to develop a national cohort to address racial and geographic disparities in stroke.  107:E7020-E7021. 2003

Five-year changes in carotid intimal-medial thickness are highly correlated between arteries and among wall segments.  107:E7036-E7036. 2003

Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells: Implications in the antiproliferative response to rapamycin.  107:911-916. 2003

Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice.  107:762-768. 2003

Use of emergency medical services in acute myocardial infarction and subsequent quality of care: Observations from the national registry of myocardial infarction 2.  106:3018-3023. 2002

Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI).  106:2537-2542. 2002

Differential modulation of lactate, pyruvate and glucose oxidation by insulin and dichloroacetate.  106:195-196. 2002

Optical mapping of V-m and Ca-i(2+) during arrhythmias induced by local perfusion of norepinephrine in cultured cell monolayers.  106:192-192. 2002

Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction.  106. 2002

Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction..  106:I131-I136. 2002

Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide.  106:1127-1132. 2002

Intramural virtual electrodes during defibrillation shocks in left ventricular wall assessed by optical mapping of membrane potential.  106:1007-1014. 2002

Fibroblast growth factor receptor-1 signaling induces osteopontin expression and vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro.  106:854-859. 2002

Mitochondrial integrity and function in atherogenesis.  106:544-549. 2002

Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure.  106:407-411. 2002

Defending the rationale for the two-tailed test in clinical research.  105:3062-3065. 2002

Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/progestin Replacement Study (HERS).  105:2962-2967. 2002

Mild renal insufficiency is associated with angiographic coronary artery disease in women.  105:2826-2829. 2002

Impact of myocardial ischemia and reperfusion on ventricular defibrillation patterns, energy requirements, and detection of recovery.  105:2537-2542. 2002

Intracellular Na⁺ concentration is elevated in heart failure but Na/K pump function is unchanged.  105:2543-2548. 2002

Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation.  105:2253-2258. 2002

Adaptation and maladaptation of the heart in diabetes: Part II: Potential mechanisms.  105:1861-1870. 2002

Adaptation and maladaptation of the heart in diabetes: Part I. General concepts.  105:1727-1733. 2002

BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy.  105:1348-1353. 2002

Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues.  105:849-854. 2002

Oral administration of an apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol.  105:290-292. 2002

Metabolic gene expression in fetal and failing human heart.  104:2923-2931. 2001

Estrogen-induced vasoprotection is independent of inducible nitric oxide synthase expression: Evidence from the mouse carotid artery ligation model.  104:2740-2745. 2001

Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction.  104:2641-2644. 2001

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation).  104:2118-2150. 2001

Association of a gene polymorphism for PAI-1 with primary pulmonary hypertension.  104:604-604. 2001

c-Jun decreases voltage-gated K⁺ channel activity in pulmonary artery smooth muscle cells.  104:1557-1563. 2001

Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors?.  104. 2001

Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors?.  104:I223-I228. 2001

Normalized diastolic properties after left ventricular assist result from reverse remodeling of chamber geometry.  104. 2001

Mechanism of ventricular defibrillation for near-defibrillation threshold shocks: A whole-heart optical mapping study in swine.  104:1313-1319. 2001

Right atrial septal electrode for reducing the atrial defibrillation threshold.  104:1066-1070. 2001

Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: A primary role of mechanical unloading underlying reverse remodeling.  104:670-675. 2001

Genetic and environmental contributions to platelet aggregation: The Framingham Heart Study.  103:3051-3056. 2001

High-energy phosphate metabolism and creatine kinase in failing hearts: A new porcine model.  103:1570-1576. 2001

Improvement of defibrillation efficacy and quantification of activation patterns during ventricular fibrillation in a canine heart failure model.  103:1473-1478. 2001

Insulin resistance and five-year progression of carotid intimal-medial wall thickness: The Insulin Resistance Atherosclerosis Study (IRAS).  103:1349-1349. 2001

Genetic variation in angiotensin-converting enzyme does not prevent development of cardiac hypertrophy or upregulation of angiotensin II in response to aortocaval fistula.  103:1012-1016. 2001

Hormone replacement therapy and stroke: Are the results surprising?.  103:620-622. 2001

Primary prevention of ischemic stroke: A statement for healthcare professionals from the stroke council of the American Heart Association.  103:163-182. 2001

Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure.  102:2713-2719. 2000

Reduction of atrial defibrillation threshold with an interatrial septal electrode.  102:2659-2664. 2000

Intramyocardial transplantation of autologous myoblasts: Can tissue processing be optimized?.  102. 2000

Intramyocardial transplantation of autologous myoblasts: can tissue processing be optimized?.  102:III210-III215. 2000

Microcirculatory effects of blocking cell adhesion molecules in transgenic sickle cell mice..  102:307-307. 2000

Septum acts as a partial barrier to wavefronts during ventricular fibrillation.  102:341-341. 2000

Shock-induced arrhythmias assessed using mapping of transmembrane potential and intracellular calcium in myocyte cultures.  102:341-341. 2000

The role of calcium current in the nonlinear changes of transmembrane potential during defibrillation shocks.  102:340-340. 2000

Chronic subclinical inflammation as part of the insulin resistance syndrome: The insulin resistance atherosclerosis study (IRAS).  102:42-47. 2000

Estrogen attenuates integrin-β3-dependent adventitial fibroblast migration after inhibition of osteopontin production in vascular smooth muscle cells.  101:2949-2955. 2000

Left ventricular apex ablation decreases the upper limit of vulnerability.  101:2458-2460. 2000

Chronic β-adrenergic stimulation induces myocardial proinflammatory cytokine expression.  101:2338-2341. 2000

Estrogen-induced vasoprotection is estrogen receptor dependent: Evidence from the balloon-injured rat carotid artery model.  101:2342-2344. 2000

Mechanism of ventricular defibrillation: The role of tissue geometry in the changes in transmembrane potential in patterned myocyte cultures.  101:2438-2445. 2000

beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling..  101:2103-2109. 2000

β-Adrenergic blockade in developing heart failure: Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling.  101:2103-2109. 2000

Pathological effects of extensive radiofrequency energy applications in the pulmonary veins in dogs.  101:1736-1742. 2000

Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries.  101:1362-1365. 2000

Influence of postshock epicardial activation patterns on initiation of ventricular fibrillation by upper limit of vulnerability shocks.  101:1329-1336. 2000

Pacing after shocks stronger than the upper limit of vulnerability: Impact on fibrillation induction.  101:1337-1343. 2000

Ventricular defibrillation with triphasic waveforms.  101:1324-1328. 2000

Clinical outcomes after ablation and pacing therapy for atrial fibrillation: A meta-analysis.  101:1138-1144. 2000

Prevention of high incidence of neurally mediated ventricular arrhythmias by afferent nerve stimulation in dogs.  101:819-824. 2000

Antiarrhythmic efficacy of dipyridamole in treatment of reperfusion arrhythmias: Evidence for cAMP-mediated triggered activity as a mechanism responsible for reperfusion arrhythmias.  101:624-630. 2000

Essential hypertension part II: Treatment.  101:446-453. 2000

Essential hypertension. Part I: Definition and etiology.  101:329-335. 2000

Bradykinin in the heart: Friend or foe?.  100:2305-2307. 1999

Risks of spontaneous injury and extraction of an active fixation pacemaker lead: Report of the accufix multicenter clinical study and worldwide registry.  100:2344-2352. 1999

Subtype specific regulation of human vascular α1-adrenergic receptors by vessel bed and age.  100:2336-2343. 1999

Harriet Pearson Dustan..  100:2122-2123. 1999

Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery.  100. 1999

Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery..  100:II340-II344. 1999

Preconditioning by mitochondrial ATP-sensitive potassium channel openers: An effective approach for improving the preservation of heart transplants.  100. 1999

Preconditioning by mitochondrial ATP-sensitive potassium channel openers: An effective approach for improving the preservation of heart transplants..  100:II345-II350. 1999

Anisotropy of membrane polarization decreases when an electrode is separated from the myocardial surface.  100:786-786. 1999

Electrotonic suppression of early and delayed afterdepolarizations in electrically coupled, isolated ventricular myocytes.  100:846-846. 1999

Heart failure changes activation patterns during ventricular fibrillation.  100:838-839. 1999

Organizational changes in atrial fibrillation produced by a single radiofrequency ablation lesion remain local to the lesion site.  100:341-342. 1999

Primary prevention of high blood cholesterol in the US, 1887-1994.  100:740-740. 1999

Radiofrequency ablation of the right atrium reduces atrial defibrillation thresholds and changes fibrillatory activity.  100:65-65. 1999

Ventricular fibrillation characteristics are different in different species.  100:310-310. 1999

Estrogen inhibits vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro.  100:1639-1645. 1999

Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension.  99:3266-3271. 1999

Opening of potassium channels the common cardioprotective link between preconditioning and natural hibernation?.  99:3079-3085. 1999

Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo.  99:2583-2589. 1999

Guide to Preventive Cardiology for Women.AHA/ACC Scientific Statement Consensus panel statement..  99:2480-2484. 1999

Guide to preventive cardiology for women.  99:2480-2484. 1999

Women versus men regarding outcome of CABG or PTCA [6] (multiple letters).  99:1925-1926. 1999

Carotid artery elasticity varies directly with educational achievement level: The ARIC Study, 1987-1992..  99:1112-1112. 1999

Insulin sensitivity and systemic atherosclerosis.  99:1115-1115. 1999

Predictors of inflammatory status in a middle-aged population.  99:1108-1108. 1999

Trends in severity of hospitalized myocardial infarction: The ARIC study 1987-1994..  99:1104-1104. 1999

Myocardial oxygenation during high work states in hearts with postinfarction remodeling.  99:942-948. 1999

Automated heparin-delivery system to control activated partial thromboplastin time: Evaluation in normal volunteers.  99:751-756. 1999

Identification of a novel genetic locus for familial cardiac myxomas and Carney complex.  98:2560-2566. 1998

Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy.  98:2404-2414. 1998

Gene polymorphisms for plasminogen activator inhibitor-1/tissue plasminogen activator and development of allograft coronary artery disease.  98:2248-2254. 1998

Relative efficacy of monophasic and biphasic waveforms for transthoracic defibrillation after short and long durations of ventricular fibrillation.  98:2210-2215. 1998

Can cellular transplantation improve function in doxorubicin-induced heart failure?.  98. 1998

Can cellular transplantation improve function in doxorubicin-induced heart failure?.  98:II151-II155. 1998

ACE-I therapy improves 30-day survival in Medicare patients recently hospitalized with congestive heart failure (CHF).  98:811-812. 1998

Alterations of intra-myocyte ion content correlate with post-cardioplegia electrophysiologic recovery.  98:750-750. 1998

Effect of defibrillation shocks on transmembrane potential in strands of cultured myocytes.  98:52-52. 1998

In vivo cardiac energetics in GLUT4-null mice.  98:627-628. 1998

Primary prevention of high blood pressure in the US, 1959-1994..  98:657-657. 1998

Pulmonary vein stenosis after catheter ablation of atrial fibrillation.  98:1769-1775. 1998

Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads.  98:1517-1524. 1998

Better outcome for women compared with men undergoing coronary revascularization: A report from the bypass angioplasty revascularization investigation (BARI).  98:1279-1285. 1998

Images in cardiovascular medicine. Improvement of myocardial perfusion after transmyocardial laser revascularization and coronary artery bypass graft surgery..  98:728-729. 1998

Marked reduction in internal atrial defibrillation thresholds with dual- current pathways and sequential shocks in humans.  97:2527-2535. 1998

Pathophysiology of sudden coronary death in women: Implications for prevention.  97:2103-2105. 1998

Evidence for association and genetic linkage of the angiotensin- converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study.  97. 1998

Myocardial discontinuities: A substrate for producing virtual electrodes that directly excite the myocardium by shocks.  97:1738-1745. 1998

Locally propagated activation immediately after internal defibrillation.  97:1401-1410. 1998

Use of reperfusion therapy for acute myocardial infarction in the United States: Data from the National Registry of Myocardial Infarction 2.  97:1150-1156. 1998

Atherosclerosis in type 2 diabetic and non-diabetic subjects with and without previous myocardial infarction: The insulin resistance atherosclerosis study (IRAS).  97:817-817. 1998

Could a decrease in the correlation between CVD risk factors underlie their smaller estimated impact on CVD in the elderly?.  97:823-823. 1998

Effect of postmenopausal hormone therapy on carbohydrate metabolism.  97:831-831. 1998

Stroke incidence rates: Seven year follow-up of the atherosclerosis risk in communities (ARIC) cohort.  97:824-824. 1998

The multiple metabolic syndrome: Increased clustering versus increased prevalence?.  97:831-831. 1998

Left ventricular thrombus.  97:412. 1998

Carotid stenting and angioplasty: A statement for healthcare professionals from the councils on cardiovascular radiology, stroke, cardio- thoracic and vascular surgery, epidemiology and prevention, and clinical cardiology, American Heart Association.  97:121-123. 1998

No role for NO in estrogen-mediated vasoprotection?.  96:2769-2771. 1997

Cognitive function 5 years after randomization to coronary angioplasty or coronary artery bypass graft surgery.  96. 1997

Does transplantation of cardiomyocytes improve function of infarcted myocardium?.  96:II-188-93. 1997

Does transplantation of cardiomyocytes improve function of infarcted myocardium?.  96. 1997

Effects of biphasic shocks on the spatial distribution of the transmembrane potential.  96:688-688. 1997

Excitation of cardiac tissue by defibrillation shocks: Role of microscopic tissue geometry.  96:683-683. 1997

Internal cardioversion of atrial fibrillation: Marked reduction in defibrillation threshold with dual current pathways.  96:2693-2700. 1997

Intravenous amiodarone increases ventricular fibrillation organization without increasing wavelength.  96:4188-4188. 1997

L-arginine protects against xanthine oxidase-dependent vascular injury in hypercholesterolemic rabbits.  96:2327-2327. 1997

Quantitative characteristic of reentrant pathways change during the first 44 seconds of ventricular fibrillation.  96:687-687. 1997

Local delivery of ethanol inhibits intimal hyperplasia in pig coronary arteries after balloon injury.  96:2295-2301. 1997

Myocardial infarction and cardiac mortality in the bypass angioplasty revascularization investigation (BARI) randomized trial.  96:2162-2170. 1997

Estrogen restores endothelial cell function in an experimental model of vascular injury.  96:1624-1630. 1997

Effects of transvenous electrode polarity and waveform duration on the relationship between defibrillation threshold and upper limit of vulnerability.  96:1351-1359. 1997

Regional disparities in the incidence of elevated blood pressure among young adults: The CARDIA study.  96:1082-1088. 1997

Relationships between myocardial bioenergetic and left ventricular function in hearts with volume-overload hypertrophy.  96:334-343. 1997

Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group..  95:1479-1486. 1997

Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension.  95:1479-1486. 1997

Elective stenting of the extracranial carotid arteries.  95:376-381. 1997

Prediction of outcome of patients with life-threatening ventricular arrhythmias treated with automatic implantable cardioverter-defibrillators using SPECT perfusion imaging.  95:390-394. 1997

Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment.  95:1301-1307. 1997

Termination of ventricular tachycardia in the human heart: Insights from three-dimensional mapping of nonsustained and sustained ventricular tachycardias.  95:2528-2540. 1997

Three-dimensional mapping of the initiation of nonsustained ventricular tachycardia in the human heart.  95:2517-2527. 1997

Transesophageal echocardiographic assessment of papillary muscle rupture [6] (multiple letters).  96:2737-2738. 1997

Secular trends in cardiac transplant recipient and donor management in the United States, 1990 to 1994. A multi-institutional study. Cardiac Transplant Research Database Group..  94:2883-2889. 1996

Can grafted cardiomyocytes colonize peri-infarct myocardial areas?.  94. 1996

Can grafted cardiomyocytes colonize peri-infarct myocardial areas?.  94:II337-II340. 1996

Evidence for an involvement of the neutrophil integrin lymphocyte function-associated antigen-1 in early failure of heart transplants.  94. 1996

Evidence for an involvement of the neutrophil integrin lymphocyte function-associated antigen-1 in early failure of heart transplants..  94:II254-II259. 1996

Differential postshock activation pattern of successful and failed defibrillation shocks of the same shock strength.  94:3325-3325. 1996

Quantitative analysis of the effects of dofetilide on ventricular fibrillation activation fronts and its relationship to defibrillation threshold in pigs.  94:1429-1429. 1996

Stationary reentrant circuits are rare during ventricular fibrillation in pigs.  94:271-271. 1996

Insulin Sensitivity and Atherosclerosis.  93:1809-1817. 1996

Insulin sensitivity and atherosclerosis.  93:1809-1817. 1996

Management of patients with atrial fibrillation: A statement for healthcare professionals from the subcommittee on electrocardiography and electrophysiology, American Heart Association.  93:1262-1277. 1996

Relation between activated clotting time during angioplasty and abrupt closure.  93:667-671. 1996

Enhanced regional deformation at the anterior papillary muscle insertion site after chordal transsection.  93:585-593. 1996

Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery.  93:577-584. 1996

Ethnic differences in carotid wall thickness: The insulin resistance atherosclerosis study (IRAS).  93:P25-P25. 1996

Passive and active smoking are related to progression or atherosclerosis.  93:22-22. 1996

Asymptomatic cardiac ischemia pilot (ACIP) study: Relationship between exercise-induced and ambulatory ischemia in patients with stable coronary disease.  94:1537-1544. 1996

Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias.  94:1585-1591. 1996

Functional and bioenergetic consequences of postinfarction left ventricular remodeling in a new porcine model MRI and ³¹P-MRS study.  94:1089-1100. 1996

Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery.  94:2221-2227. 1996

Secular trends in cardiac transplant recipient and donor management in the United States, 1990 to 1994: A multi-institutional study.  94:2883-2889. 1996

Transesophageal echocardiographic assessment of papillary muscle rupture.  94:1003-1009. 1996

Selection and treatment of candidates for heart transplantation: A statement for health professionals from the committee on heart failure and cardiac transplantation of the council on clinical cardiology, American Heart Association.  92:3593-3612. 1995

Influence of epicardial patches on defibrillation threshold with nonthoracotomy lead configurations.  92:3082-3088. 1995

Asymptomatic cardiac ischemia pilot (ACIP) study: Improvement of cardiac ischemia at 1 year after PTCA and CABG.  92. 1995

Hypothermia during cardiopulmonary bypass delays but does not prevent neutrophil-endothelial cell adhesion. A clinical study..  92:II354-II358. 1995

Influence of temperature on neutrophil trafficking during clinical cardiopulmonary bypass.  92. 1995

Influence of temperature on neutrophil trafficking during clinical cardiopulmonary bypass..  92:II334-II340. 1995

Postextrasystolic mechanical restitution in closed-chest dogs: Effect of heart failure.  92:2652-2659. 1995

ANODAL AND CATHODAL POINT STIMULATION PRODUCE ACTION-POTENTIAL PROLONGATION IN REGIONS OF DEPOLARIZATION.  92:1431-1431. 1995

DIRECT LINK BETWEEN GAP JUNCTION REMODELING AND CHANGES IN CONDUCTION IN CULTURED MYOCYTES.  92:189-189. 1995

RELATION BETWEEN GAP JUNCTION DISTRIBUTION AND ANISOTROPIC ACTIVATION SPREAD IN CULTURED MONOLAYERS OF NEONATAL RAT MYOCYTES.  92:188-188. 1995

Effects of premature beats on repolarization of postextrasystolic beats.  92:1969-1980. 1995

Endocardial carbon-braid electrodes: A new concept for lower defibrillation thresholds.  92:1627-1633. 1995

Effect of rapid pacing and T-wave scanning on the relation between the defibrillation and upper-limit-of-vulnerability dose-response curves.  92:1291-1299. 1995

Bioenergetic consequences of left ventricular remodeling.  92:1011-1019. 1995

Nonreentrant mechanisms underlying spontaneous ventricular arrhythmias in a model of nonischemic heart failure in rabbits.  92:1034-1048. 1995

The risk of atrial fibrillation following radiofrequency catheter ablation of atrial flutter.  92:430-435. 1995

Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis: Results from the TIMI II study.  91:2541-2548. 1995

Cardiovascular health at the crossroads: outlook for the 21st century. Presented at the 67th Scientific Sessions of the American Heart Association November 4, 1994 Dallas, Texas..  91:1304-1310. 1995

Comparison of upper limit of vulnerability and defibrillation probability of success curves using a nonthoracotomy lead system.  91:1247-1252. 1995

DOES THE ASSOCIATION OF RISK-FACTORS AND ATHEROSCLEROSIS CHANGE WITH AGE - A COMBINED ANALYSIS OF THE ARIC AND CHS COHORTS.  91:931-931. 1995

IS THE STROKE BELT DISAPPEARING - AN ANALYSIS OF RACIAL AND TEMPORAL EFFECTS.  91:938-938. 1995

Improved defibrillation threshold with a new epicardial carbon electrode compared with a standard epicardial titanium patch.  91:445-450. 1995

Coarctation of the aorta and ventricular septal defect.  91:1263. 1995

Effect of left ventricular hypertrophy secondary to chronic pressure overload on transmural myocardial 2-deoxyglucose uptake: A ³¹P NMR spectroscopic study.  92:1274-1283. 1995

Effect of tachycardia heart failure on the restitution of left ventricular function in closed-chest dogs.  91:176-185. 1995

Fighting the NIH funding crisis.  91:2502. 1995

Hypothermia during cardiopulmonary bypass delays but does not prevent neutrophil-endothelial cell adhesion: A clinical study.  92. 1995

Preventing heart attack and death in patients with coronary disease.  92:2-4. 1995

Does normothermia during cardiopulmonary bypass increase neutrophil-endothelium interactions?.  90:II275-II279. 1994

Metabolic and functional evidence that retrograde warm blood cardioplegia does not injure the right ventricle in human beings..  90:II310-II315. 1994

2-DIMENSIONAL HIGH-RESOLUTION OPTICAL MAPPING OF ANISOTROPIC IMPULSE CONDUCTION IN NEONATAL RAT-HEART CEL MONOLAYERS.  90:40-40. 1994

CALCULATION OF ABSOLUTE METABOLIC FLUXES IN THE PERFUSED RAT-HEART BY C-13 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY.  90:629-629. 1994

CONDUCTION-VELOCITY AND SHAPE OF ACTION-POTENTIAL UPSTROKE IN A COMPUTER-MODEL OF AN ANISOTROPIC HEART CELL MONOLAYER.  90:411-411. 1994

PLASMA-CONCENTRATIONS OF LP(A) DISTINGUISH FEMALE BUT NOT MALE CORONARY-DISEASE CASES FROM CONTROLS.  90:509-509. 1994

Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction..  90:2103-2114. 1994

RACIAL-DIFFERENCES IN CAROTID-ARTERY WALL THICKNESS IN MIDDLE-AGED ADULTS.  89:939-939. 1994

SOCIOECONOMIC-STATUS AFFECTS THE EXCESS BLACK STROKE MORTALITY - THE NATIONAL-LONGITUDINAL-MORTALITY-STUDY.  89:939-939. 1994

Does normothermia during cardiopulmonary bypass increase neutrophil- endothelium interactions?.  90. 1994

Focal mechanisms underlying ventricular tachycardia during prolonged ischemic cardiomyopathy.  90:1441-1458. 1994

Intramachine and intermachine variability in transesophageal color Doppler images of pulsatile jets: In vitro studies.  89:2141-2149. 1994

Magnetic resonance imaging of chronic myocardial infarcts in formalin- fixed human autopsy hearts.  89:2133-2140. 1994

Metabolic and functional evidence that retrograde warm blood cardioplegia does not injure the right ventricle in human beings.  90:310-315. 1994

Mithramycin inhibits myointimal proliferation after balloon injury of the rat carotid artery in vivo.  90:2468-2473. 1994

Scar remodeling and transmural deformation after infarction in the pig.  90:411-420. 1994

Treatment of myocardial infarction in the United States (1990 to 1993): Observations from the National Registry of Myocardial Infarction.  90:2103-2114. 1994

Influence of left ventricular assist on valvular regurgitation..  88:II309-II318. 1993

Report of the task force on children and youth. American Heart Association..  88:2479-2486. 1993

Race and prognosis after myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial..  88:1484-1494. 1993

TISSUE GEOMETRY AS A DETERMINANT OF UNIDIRECTIONAL CONDUCTION BLOCK - ASSESSMENT OF MICROSCOPIC EXCITATION SPREAD BY OPTICAL MAPPING IN PATTERNED MYOCYTE CULTURES.  88:623-623. 1993

Internal cardioversion of atrial fibrillation in sheep.  87:1673-1686. 1993

Race and prognosis after myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial.  88:1484-1494. 1993

Report of the task force on children and youth.  88:2479-2485. 1993

Rejection after cardiac transplantation. A time-related risk factor analysis..  86:II236-II241. 1992

ALTERATIONS IN MYOCARDIAL GLUCOSE-METABOLISM IN DIABETES-INDUCED HEART-FAILURE.  86:281-281. 1992

DISCONTINUOUS IMPULSE PROPAGATION AT A CELLULAR-LEVEL IN CULTURED STRANDS OF NEONATAL RAT-HEART CELLS.  86:752-752. 1992

OPTICAL VERSUS ELECTRICAL DETECTION OF RAPID MEMBRANE-POTENTIAL CHANGES IN CULTURED NEONATAL RAT-HEART CELLS.  86:820-820. 1992

PASSIVE SMOKING AND CAROTID-ARTERY WALL THICKNESS - THE ARIC STUDY.  85:862-862. 1992

Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure: Results of a multicenter trial.  85:942-949. 1992

Cardiac potential and potential gradient fields generated by single, combined, and sequential shocks during ventricular defibrillation.  85:1510-1523. 1992

Cardiac transplantation: Recipient selection, donor procurement, and medical follow-up: A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association.  86:1061-1079. 1992

Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study.  86:1206-1216. 1992

Contribution of myocardium responsible for ventricular tachycardia to abnormalities detected by analysis of signal-averaged ECGs.  86:1888-1901. 1992

Coronary angioplasty in cardiac transplant patients: Results of a multicenter study.  86:458-462. 1992

Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery: A report from the Coronary Artery Surgery Study (CASS) registry.  86:446-457. 1992

Effect of intravenous adenosine infusion on myocardial perfusion and function: Hemodynamic/angiographic and scintigraphic study.  86:887-895. 1992

Effect of pulse separation between two sequential biphasic shocks given over different lead configurations on ventricular defibrillation efficacy.  85:2267-2274. 1992

Familial lipoprotein disorders in patients with premature coronary artery disease.  85:2025-2033. 1992

High-current stimuli to the spared epicardium of a large infarct induce ventricular tachycardia.  85:680-698. 1992

Importance of intraluminal pressure on hemodynamics and vasoconstriction responses of stenotic arteries.  85:708-716. 1992

Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart.  86:1872-1887. 1992

Selective radiofrequency ablation of the slow pathway for the treatment of atrioventricular nodal reentrant tachycardia: Evidence for involvement of perinodal myocardium within the reentrant circuit.  85:1675-1688. 1992

Three-dimensional potential gradient fields generated by intracardiac catheter and cutaneous patch electrodes.  85:1857-1864. 1992

Echocardiographic assessment of prosthetic valves..  84:I228-I239. 1991

Immediate versus deferred β-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) II-B study.  83:422-437. 1991

Induction of myocardial hypertrophy after coronary ligation in rats decreases ventricular dilatation and improves systolic function.  84:1819-1827. 1991

Mechanism of cardiac defibrillation: A different point of view.  84:913-919. 1991

Relation of risk factor levels in young adulthood to parental history of disease: The CARDIA study.  84:1176-1187. 1991

Response of relatively refractory canine myocardium to monophasic and biphasic shocks.  84:2522-2538. 1991

Usefulness of transesophageal echocardiography in assessment of aortic dissection.  84:1903-1914. 1991

Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans.  82. 1990

Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans..  82:IV390-IV396. 1990

DECLINING STROKE MORTALITY - ESTIMATES OF THE RELATIVE ROLE OF INCIDENCE AND CASE FATALITY.  81:712-712. 1990

TREATMENT OF OBESITY HYPERTENSION.  81:723-723. 1990

Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator: Results of the thrombolysis in myocardial infarction (TIMI) phase II-A trial.  81:1457-1476. 1990

Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans.  82. 1990

Lipoprotein and oxygen transport alterations in passive smoking preadolescent children. The MCV Twin Study.  81:586-592. 1990

Resetting of ventricular tachycardia by single extrastimuli. Relation to slow conduction within the reentrant circuit.  81:1507-1519. 1990

Strength-duration and probability of success curves for defibrillation with biphasic waveforms.  82:2128-2141. 1990

Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery. The Coronary Artery Surgery Study (CASS).  82:1647-1658. 1990

Two-dimensional echocardiography and Doppler color flow mapping in the diagnosis and prognosis of ventricular septal rupture.  81:1775-1783. 1990

Adequate preservation of right ventricular function after coronary sinus cardioplegia. A clinical study..  80:III19-III24. 1989

Arrhythmias after orthotopic cardiac transplantation. Prevalence and determinants during initial hospitalization and late follow-up..  80:III140-III146. 1989

Adequate preservation of right ventricular function after coronary sinus cardioplegia. A clinical study.  80:19-24. 1989

Arrhythmias after orthotopic cardiac transplantation. Prevalence and determinants during initial hospitalization and late follow-up.  80:140-146. 1989

Asymptomatic left main coronary artery disease in the Coronary Artery Surgery Study (CASS) registry.  79:1171-1179. 1989

Cardioplegic arrest superimposed on evolving myocardial ischemia. Improved recovery after inhibition of hydroxyl radical generation by peroxidase or deferoxamine. A 31P nuclear resonance study..  78:III164-III172. 1988

Cardioplegic arrest superimposed on evolving myocardial ischemia. Improved recovery after inhibition of hydroxyl radical generation by peroxidase of deferoxamine. A ³¹P nuclear resonance study.  78. 1988

Cryosurgical ablation of atrioventricular nodal reentry: Histologic localization of the proximal common pathway.  77:1356-1362. 1988

Mitral valve prolapse in patients with prior rheumatic fever.  77:830-836. 1988

Right ventricular diastolic pressure-volume relations and regional dimensions during acute alterations in loading conditions.  77:1276-1282. 1988

Prevention of hydroxyl radical formation: a critical concept for improving cardioplegia. Protective effects of deferoxamine..  76:V180-V185. 1987

Calibration of color Doppler flow mapping during extreme hemodynamic conditions in vitro: A foundation for a reliable quantitative grading system for aortic incompetence.  75:837-846. 1987

Color Doppler assessment of mitral regurgitation with orthogonal planes.  75:175-183. 1987

Color Doppler evaluation of aortic dissection.  75:748-755. 1987

Cryosurgical treatment of atrioventricular node reentrant tachycardia.  76:1329-1336. 1987

Electrophysiologic mechanisms underlying arrhythmias due to reperfusion of ischemic myocardium.  76:404-426. 1987

Hemodynamically important right ventricular infarction: Follow-up evaluation of right ventricular systolic function at rest and during exercise with radionuclide ventriculography and respiratory gas exchange.  75:996-1003. 1987

Improved defibrillation thresholds with large contoured epicardial electrodes and biphasic waveforms.  76:1176-1184. 1987

The relationship of various measures of end-systole to left ventricular maximum time-varying elastance in man.  76:32-43. 1987

Enhancement of cardioplegic protection with the free-radical scavenger peroxidase.  74. 1986

Enhancement of cardioplegic protection with the free-radical scavenger peroxidase..  74:III138-III144. 1986

Clinical and prognostic importance of persistent precordial (V1-V4) electrocardiographic ST segment depression in patients with inferior transmural myocardial infarction.  74:56-63. 1986

Comparison of the defibrillation threshold and the upper limit of ventricular vulnerability.  73:1022-1028. 1986

Intraventricular tunnel repair for Taussig-Bing heart and related cardiac anomalies.  74:53-60. 1986

Quantitative analysis of myocardial infarct structure in patients with ventricular tachycardia.  74:1266-1279. 1986

The effect of chemical ablation of the endocardium on ventricular fibrillation threshold.  74:645-652. 1986

The potential gradient field created by epicardial defibrillation electrodes in dogs.  74:626-636. 1986

Intermediate-term results of coronary artery bypass grafting for acute myocardial infarction..  72. 1985

Comparative effects of volume loading, dobutamine, and nitroprusside in patients with predominant right ventricular infarction.  72:1327-1335. 1985

Immediate functional recovery and avoidance of reperfusion injury with surgical revascularization of short-term coronary occlusion.  72:431-439. 1985

Validation of attenuation-corrected equilibrium radionuclide angiographic determinations of right ventricular volume: Comparison with cast-validated biplane cineventriculography.  72:317-326. 1985

A randomized comparison of crystalloid and blood-containing cardioplegic solutions in 60 patients.  69:973-982. 1984

Comparison of enzymatic and anatomic estimates of myocardial infarct size in man.  70:824-835. 1984

Prosthetic valve endocarditis.  69:223-232. 1984

Return of left ventricular function after reperfusion in patients with myocardial infarction: Importance of subtotal stenoses or intact collaterals.  69:338-349. 1984

A life table and Cox regression analysis of patients with combined proximal left anterior descending and proximal left circumflex coronary artery disease: Non-left main equivalent lesions (CASS).  68:1163-1170. 1983

A mechanism of torsades de pointes in a canine model.  67:52-59. 1983

Correlation of echocardiographic wall stress and left ventricular pressure and function in aortic stenosis.  67:854-859. 1983

Evaluation of high-energy phosphate metabolism during cardioplegic arrest and reperfusion: A phosphorus-31 nuclear magnetic resonance study.  67:1296-1303. 1983

Variation in the size of jeopardized myocardium in patients with isolated left anterior descending coronary artery disease.  67:988-994. 1983

Costs and benefits associated with treatment for coronary artery disease.  66. 1982

Epidemiologic study of candidates for coronary artery bypass surgery..  66:III6-II15. 1982

Assessment of jeopardized myocardium in patients with one-vessel disease.  65:242-247. 1982

Employment status after coronary artery bypass surgery.  65. 1982

Epidemiologic study of candidates for coronary artery bypass surgery.  66. 1982

Evaluation of a QRS scoring system for estimating myocardial infarct size. I. Specificity and observer agreement.  65:342-347. 1982

Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man.  66:49-55. 1982

Two-dimensional echocardiographic features of right ventricular infarction.  65:167-173. 1982

Treatment of infective endocarditis due to viridans streptococci. This statement was prepared by the ad hoc subcommittee on treatment of bacterial endocarditis of the American Heart Association Council on cardiovascular disease in the young.  63. 1981

A simplified valve formula for the calculation of stenotic cardiac valve areas.  63:1050-1055. 1981

Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS).  64:360-367. 1981

Correlation of the width of the QRS complex with the pathologic anatomy of the cardiac conduction system in patients with chronic complete atrioventricular block.  63:938-947. 1981

Myocardial infarct size and location in relation to the coronary vascular bed at risk in man.  64:526-534. 1981

Real-time, two-dimensional echocardiographic features of pacemaker perforation.  64:97-106. 1981

The transition to ventricular fibrillation induced by reperfusion after acute ischemia in the dog: A period of organized epicardial activation.  63:1371-1379. 1981

Two-dimensional echocardiographic features of atrial septal aneurysms.  63:452-457. 1981

Two-dimensional echocardiographic identification of papillary muscles..  64:651-652. 1981

Surgical vs nonsurgical management of patients after myocardial infarction.  62. 1980

Detection of residual jeopardized myocardium 3 weeks after myocardial infarction by exercise testing with thallium-201 myocardial scintigraphy.  61:729-737. 1980

Drug management of hypertension.  61:210-212. 1980

Quantitative difference in 'critical' stenosis between right and left coronary artery in man.  62:1188-1196. 1980

A computerized method for the rapid display of ventricular activation during the intraoperative study of arrhythmias.  59:449-458. 1979

Effect of filming projection and interobserver variability on angiographic biplane left ventricular volume determination.  59:96-104. 1979

Epicardial mapping of the onset of ventricular tachycardia initiated by programmed stimulation in the canine heart with chronic infarction.  60:1375-1384. 1979

Impaired maximal rate of left ventricular relaxation in patients with coronary artery disease and left ventricular dysfunction.  59:984-991. 1979

Unstable angina pectoris. An examination of modes and costs of therapy.  60. 1979

Usefulness and limitations of thallium-201 myocardial scintigraphy in delineating location and size of prior myocardial infarction.  59:1010-1019. 1979

Anomalous aortic origin of coronary arteries.  58:606-615. 1978

Changes in left ventricular segmental wall motion following randomization to medicine or surgery in patients with unstable angina..  58. 1978

Chronotropic effects of tetraethylammonium and 4-aminopyridine in canine sinus node pacemaker cells.  58. 1978

Echocardiographic evaluation of intracardiac pacing catheters: M-mode and two-dimensional studies.  58:1049-1056. 1978

Effect of glucose-insulin-potassium infusion during pacing.  58. 1978

Evaluation of asynergy as an indicator of myocardial fibrosis.  57:715-725. 1978

Left ventricular aneurysmectomy in patients with single vs multivessel coronary artery disease..  58. 1978

The bruit of carotid stenosis versus radiated basal heart murmurs: Differentiation by phonoangiography.  57:975-981. 1978

The mechanism of post-arrhythmic renal vasoconstriction in the dog.  58. 1978

Treatment of infective endocarditis: A 10-year comparative analysis.  58:589-597. 1978

Correlation of angiographic estimates of myocardial infarct size and accumulated release of creatine kinase MB isoenzyme in man.  56:199-205. 1977

Correlation of postmortem anatomic findings with electrocardiographic changes in patients with myocardial infarction. Retrospective study of patients with typical anterior and posterior infarcts.  55:279-285. 1977

Improved outcome for prehospital cardiopulmonary collapse with resuscitation by bystanders.  56:901-905. 1977

Left precordial isopotential mapping during supine exercise.  56:245-252. 1977

Quantitative assessment of ventricular performance in unstable ischemic heart disease by dextran function curves.  55:858-863. 1977

Technetium 99m stannous pyrophosphate myocardial scintigraphy. Reliability and limitations in assessment of acute myocardial infarction.  56:192-198. 1977

Glucose insulin potassium, free fatty acids and acute myocardial infarction in man.  53. 1976

Anginal threshold and glucose-insulin-potassium in unstable ischemic heart disease.  54. 1976

Echocardiographic studies of abnormalities associated with coarctation of the aorta.  53:953-956. 1976

Echocardiography of cardiac valves in pericardial effusion.  54:500-504. 1976

Influence of [Mg²⁺] on activity of sinus node pacemaker cells.  54. 1976

Sinus bradyarrhythmia and impaired response to norepinephrine caused by low extracellular sodium.  54. 1976

Structural requirements for the inhibition of renin release in vitro by the angiotensins.  54. 1976

Simultaneous operative correction of aortic valve stenosis and idiopathic hypertrophic subaortic stenosis.  52:34-39. 1975

Analysis of components in a cardiogenic hyertensive chemoreflex.  52:179-192. 1975

Canine atrial and ventricular muscle mechanics studied as a function of age.  52. 1975

Echocardiographic features of subpulmonic obstruction in dextro transposition of the great vessels.  51:515-521. 1975

Echocardiography of the intra atrial baffle in dextro transposition of the great vessels.  51:1130-1135. 1975

Echocardiography of the tricuspid valve in congenital left ventricular right atrial communication.  51:268-272. 1975

Localization of heart vectors produced by pairs of epicardial burns: validation of a two dipole ranging method.  52. 1975

Mitral commissurotomy versus replacement. Preoperative evaluation by echocardiography.  51:263-267. 1975

Simultaneous operative correction of aortic valve stenosis and idiopathic hypertrophic subaortic stenosis.  No. 45. 1975

Echocardiographic evaluation of pulmonary hypertension.  50:575-581. 1974

Echocardiographic recognition of the congenital bicuspid aortic valve.  49:870-875. 1974

Echocardiography in the diagnosis of idiopathic hypertrophic subaortic stenosis co existing with aortic valve disease.  50:752-757. 1974

Morphine selectively perfused into the sinus node of awake dogs.  50. 1974

Diagnosis of aortic root dissection by echocardiography.  48:506-513. 1973

Echocardiographic assessment of left ventricular outflow width in the selection of mitral valve prosthesis..  48:1208-1214. 1973

Prosthetic valve endocarditis: analysis of 38 cases.  48:365-377. 1973

Decreased carotid flow with ascending aortic cannulation..  45. 1972

Role of renin in acute postural homeostasis..  41:89-95. 1970